Clinical efficacy and tolerability of a new levodopa/benserazide dual- release formulation in parkinsonian patients

Clinical Neuropharmacology

Volumn 20, Issue 2, 1997, Pages 130-139

  Ghika, J ^a   Gachoud, J P ^b   Gasser, U ^b   Beck Fohn, M ^c   Burgunder, J M ^c   Corbat, F ^c   Curchod, J ^c   Dessibourg, C A ^c   Dufresne, J J ^c   Ferel, D ^c   Ferrazzini, M ^c   Friedli, P ^c   Gschwend, G ^c   Hess, Ch ^c   Hew Winzeler, A M ^c   Jenik, F ^c   Jenzer, G ^c   Justafre J C ^c   Kasper, U ^c   Ludin, H P ^c   Markoff, R ^c   Meienberg, O ^c   Meyer, Ch ^c   Nancoz R B ^c   Rast, N ^c   Riederer, E ^c   Rouselle, J ^c   Steck, A ^c   Stockli H R ^c   Tosi, C ^c   Tscholl, R J ^c   more..

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Roche Pharma Schweiz AG   (Switzerland)

^c NONE

Author keywords

Benserazide; Dual release formulation; Levodopa; Parkinson's disease; Slow release

Indexed keywords

BENSERAZIDE; LEVODOPA;

ADULT; AGED; ARTICLE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SCORING SYSTEM; SUSTAINED DRUG RELEASE;

EID: 0031004259     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199704000-00004     Document Type: Article

References (24)

1. Rinne UK, Rinne JO. Madopar HBS in the treatment of early Parkinson's disease. In: Agnoli A, Campanella G, eds. New developments in therapy of Parkinson's disease. Proceedings of the European conference on Parkinson's disease and extrapyramidal disorders. Rome, 1990. 1990:17-22. John Libbey, CIC, New York.
2. Olanow CW, Nakano K, Nausieda P, et al. An open multicenter trial of Sinemet CR in levodopa-naive Parkinson's disease patients. Clin Neuropharmacol 1991;14:235-40.
3. Poewe WH, Lees AJ, Stern GM. Treatment of motor fluctuations in Parkinson's disease with an oral sustained-release preparation of L-dopa: clinical and pharmacokinetic observations. Clin Neuropharmacol 1986;9:430-9.
4. Juncos JL, Fabbrini G, Mouradian MM, Serrati C, Kask AM, Chase TN. Controlled release levodopa treatment of motor fluctuations in Parkinson's disease. J Neurol Neurosurg Psychiatry 1987;50:194-8.
5. Rinne UK. Madopar HBS in the long-term treatment of parkinsonian patients with fluctuations in disability. Eur Neurol 1987;27(suppl 1):120-5.
6. Goetz CG, Tanner CM, Shannon KM, et al. Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations. Neurology 1988;38:1143-6.
7. Bush DF, Liss CL, Morton A for the Multicenter Study Group. An open multicenter long-term treatment for evaluation of Sinemet CR. Neurology 1989;39:(suppl 2):101-4.
8. Cedarbaum JM, Hoey M, McDowell F. A double-blind crossover comparison of Sinemet CR 4 and standard Sinemet 25/100 in patients with Parkinson's disease and fluctuating motor performance. J Neurol Neurosurg Psychiatry 1989;52:207-12.
9. Factor SA, Sanchez-Ramos JR, Weiner WJ, Ingenito AM. Efficacy of Sinemet CR4 in subgroups of patients Psychiatry 1989;52:207-12.
10. Feldman RG, Musbach PA, Kelly MR, Thomas CA, Saint-Hilaire MH. Double-blind comparison of standard Sinemet and Sinemet CR in patients with mild-to-moderate Parkinson's disease. Neurology 1989;(suppl 2):96-101.
11. Rondot P, Ziegler M, Aymard N, Teinturier A. Effect of controlled-release carbidopa/levodopa on motor performances in advanced Parkinson's disease, Neurology 1989;39(suppl 2):74-7.
12. Yeh KC, August TF, Bush DF, et al. Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies. Neurology 1989;39(suppl 2):25-38.
13. Ceballos-Baumann AO, von Kummer R, Eckert W, Weicher H. Controlled-release levodopa-benzerazide (Madopar HBS): clinical observations and levodopa and dopamine plasma levels concentrations in fluctuating parkinsonian patients. J Neurol 1990;237:24-8.
14. MacMahon DG, Sachdev D, Broche HG, Ellis CJK, Kendal BK, Blackburn NA. A comparison of the effects of controlled-release levodopa (Madopar CR) with conventional levodopa in Parkinson's disease. J Neurol Neurosurg Psychiatry 1990;53:220-3.
15. Stocchi F, Giorgi I, Bravi D, et al. A multicenter trial with Madopar HBS in fluctuatory parkinsonian patients, In: Agnoli A, Campanella G, eds. New developments in the therapy of Parkinson's Rome, 1990. 1990:29-32. John Libbey, CIC, New York.
16. Pahwa R, Busenbank K, Huber SJ, Michalek D, Hubbh JP, Koller WC. Clinical experience with controlled release carbidnpa/levodopa in Parkinson's disease. Neurology 1993;43:667-81.
17. Jansen ENH, Meerwaldt JD. Madopar HBS in nocturnal symptoms of Parkinson's disease. In: Streifler MB, Korczyn AD, Melamed E, Youdim MBH. Parkinson's disease: anatomy, pathology and therapy. New York: Raven Press, 1990:527-31. (Advances in neurology; vol 53.
18. Trenkwalder C, Wagner M, Gasser T, Poewe W, Oertel WH. Long-term treatment with slow-release levodopa (Madopar HBS) in parkinsonian patients with nocturnal disabilities. In: Agnoli A, Campanella G, eds. New developments in the therapy of parkinson's disease. Proceedings of the European conference on Parkinson's disease and extrapyramidal disorders. Rome, 1990. 1990:22-7. John Libbey, CIC, New York.
19. The UK Madopar HBS Study group. A comparison of Madopar HBS and standard Madopar in the treatment of nocturnal and early-morning disability in parkinson's disease. Clin Neuropharmacol 1990;12:498-505.
20. Conte U, Maggi L, Colombo P, LaManna A. Multi-layered hydrophilic matrixes as a constant release device (Geometrix TM Systems). J Controlled Release 1993;26:39-47. Muttenz, Switzerland.
21. Hoehn MM, Yahr MD. Parkinsonism: Onset, progression and mortality Neurology 1967;17:427-12.
22. Webster DD. Critical analysis of disability in Parkinson disease. Med Treatment 1968;5:257-82.
23. Fahn S, Elton RL, and members of the UPDRS Committee Unified Parkinson's, Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, eds. Recent developments in Parkinson's disease, vol II. Florham Park, NJ: Macmillan, 1987:153-63.
24. Hughs AJ, Daniel SE, Blankson S, Lees AJ. A clinico pathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140-8.